Skip to main content
OpenTrials

Clinical trial condition

Retroviridae Infections

Explore clinical trials studying Retroviridae Infections. Study availability and eligibility vary by location and protocol.

5,663 public trials 308 recruiting studies
Refine in advanced search Browse all conditions

Retroviridae Infections trial results

Completed

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

NCT00013520

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • USC CRS Los Angeles, California, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Stanford CRS Palo Alto, California, United States
View all 60 locations
View Trial Details
Completed

Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328

NCT00000923

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • USC CRS Los Angeles, California, United States
  • Harbor-UCLA Med. Ctr. CRS Torrance, California, United States
  • Univ. of Hawaii at Manoa, Leahi Hosp. Honolulu, Hawaii, United States
View Trial Details
Completed

Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen

NCT00000903

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • USC CRS Los Angeles, California, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Stanford CRS Palo Alto, California, United States
View all 50 locations
View Trial Details
Completed

A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure

NCT00000918

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • Univ of Southern California / LA County USC Med Ctr Los Angeles, California, United States
  • UCLA CARE Ctr Los Angeles, California, United States
  • Willow Clinic Menlo Park, California, United States
View all 39 locations
View Trial Details
Completed

A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)

NCT00001020

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • St Louis Univ School of Medicine St Louis, Missouri, United States
  • Univ of Pennsylvania at Philadelphia Philadelphia, Pennsylvania, United States
  • Children's Hospital & Medical Center / Seattle ACTU Seattle, Washington, United States
View Trial Details
Completed

Study of Anti-HIV Therapy Intensification

NCT00034086

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • Rush Univ. Med. Ctr. ACTG CRS Chicago, Illinois, United States
  • Case CRS Cleveland, Ohio, United States
View Trial Details
Completed

A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS

NCT00000674

Conditions
AIDS-Related Opportunistic Infections, Abscess, Acquired Immunodeficiency Syndrome, +31 more
Locations
  • USC CRS Los Angeles, California, United States
  • Stanford CRS Palo Alto, California, United States
  • Ucsd, Avrc Crs San Diego, California, United States
  • Univ. of Miami AIDS CRS Miami, Florida, United States
View all 13 locations
View Trial Details
Completed

Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis

NCT00145249

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +24 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • Harbor-UCLA Medical Center Los Angeles, California, United States
  • University of Colorado Denver, Colorado, United States
View all 15 locations
View Trial Details
Completed

H1N1 Vaccine at Two Dose Levels in HIV Positive Adults

NCT00992433

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +18 more
Locations
  • University of Iowa Iowa City, Iowa, United States
  • University of Maryland Baltimore - Institute of Human Virology Baltimore, Maryland, United States
  • Saint Louis University St Louis, Missouri, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details

Related conditions